XML 123 R99.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-Based Compensation Share-Based Compensation - Restricted Stock and Performance Shares (Details) - $ / shares
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 19.40 $ 13.86
Ending balance, Weighted Average Grant Date Fair Value $ 21.87 $ 19.40
Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 187  
Granted, Number of Share Units Outstanding 73  
Vested, Number of Share Units Outstanding 52  
Forfeited, Number of Share Units Outstanding (4)  
Ending balance, Number of Share Units Outstanding 204 187
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 50.62  
Granted, Weighted Average Grant Date Fair Value 73.60  
Vested, Weighted Average Grant Date Fair Value 55.56  
Forfeited, Weighted Average Grant Date Fair Value 53.82  
Ending balance, Weighted Average Grant Date Fair Value $ 57.57 $ 50.62
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 161  
Granted, Number of Share Units Outstanding 58  
Net increase due to estimated performance, Number of Share Units Outstanding 49  
Vested, Number of Share Units Outstanding 117  
Forfeited, Number of Share Units Outstanding   (8)
Ending balance, Number of Share Units Outstanding 143 161
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 46.25  
Granted, Weighted Average Grant Date Fair Value 65.00  
Net increase due to estimated performance, Weighted Average Grant Date Fair Value 53.27  
Vested, Weighted Average Grant Date Fair Value 38.83  
Forfeited, Weighted Average Grant Date Fair Value   $ 51.28
Ending balance, Weighted Average Grant Date Fair Value $ 62.08 $ 46.25